New Guidelines Expand Statin Eligibility to More Than Half of US Adults
In a new analysis that used weighted data from the National Health and Nutrition Examination Survey (NHANES), researchers estimated that the updated recommendations would make an additional 21.5 million US adults eligible for statins, increasing total eligibility to 87.5 million adults, or 56.6% of those aged 30-79 years.
- 2026 AHA/ACC dyslipidemia guideline expands statin eligibility to adults 30-79 years.
- Estimated 87.5M US adults eligible for primary prevention statins; +21.5M vs 2018.
- PREVENT-ASCVD equations replace prior risk tool; low risk <3%, high risk ≥10%.
- Eligibility rises with age; largest new-eligibility increase in adults 40-59 years.
- 32.2% exceed new LDL-C targets; 76.1% of primary prevention patients untreated.
https://www.medscape.com/viewarticle/new-guidelines-expand-statin-eligibility-more-than-half-us-2026a1000p5p
RU
EN